BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 11057904)

  • 1. Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.
    Ries S; Biederer C; Woods D; Shifman O; Shirasawa S; Sasazuki T; McMahon M; Oren M; McCormick F
    Cell; 2000 Oct; 103(2):321-30. PubMed ID: 11057904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
    Phelps M; Darley M; Primrose JN; Blaydes JP
    Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras inhibition leads to transcriptional activation of p53 and down-regulation of Mdm2: two mechanisms that cooperatively increase p53 function in colon cancer cells.
    Halaschek-Wiener J; Wacheck V; Kloog Y; Jansen B
    Cell Signal; 2004 Nov; 16(11):1319-27. PubMed ID: 15337531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
    Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
    Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts.
    Kurokawa K; Tanaka T; Kato J
    Oncogene; 1999 Apr; 18(17):2718-27. PubMed ID: 10348346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
    Meng X; Carlson NR; Dong J; Zhang Y
    Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes.
    Roper E; Weinberg W; Watt FM; Land H
    EMBO Rep; 2001 Feb; 2(2):145-50. PubMed ID: 11258707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.
    Pomerantz J; Schreiber-Agus N; Liégeois NJ; Silverman A; Alland L; Chin L; Potes J; Chen K; Orlow I; Lee HW; Cordon-Cardo C; DePinho RA
    Cell; 1998 Mar; 92(6):713-23. PubMed ID: 9529248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p19ARF links the tumour suppressor p53 to Ras.
    Palmero I; Pantoja C; Serrano M
    Nature; 1998 Sep; 395(6698):125-6. PubMed ID: 9744268
    [No Abstract]   [Full Text] [Related]  

  • 10. E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis.
    Rogoff HA; Pickering MT; Debatis ME; Jones S; Kowalik TF
    Mol Cell Biol; 2002 Aug; 22(15):5308-18. PubMed ID: 12101227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression.
    Meng X; Tackmann NR; Liu S; Yang J; Dong J; Wu C; Cox AD; Zhang Y
    Cancer Res; 2016 Sep; 76(17):5030-9. PubMed ID: 27402081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis.
    Moore L; Venkatachalam S; Vogel H; Watt JC; Wu CL; Steinman H; Jones SN; Donehower LA
    Oncogene; 2003 Oct; 22(49):7831-7. PubMed ID: 14586409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of p38δ expression plays an essential role in oncogenic ras-induced senescence.
    Kwong J; Chen M; Lv D; Luo N; Su W; Xiang R; Sun P
    Mol Cell Biol; 2013 Oct; 33(19):3780-94. PubMed ID: 23878395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
    Eischen CM; Alt JR; Wang P
    Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
    Lin AW; Lowe SW
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
    Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
    Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts.
    Khan S; Guevara C; Fujii G; Parry D
    Oncogene; 2004 Aug; 23(36):6040-6. PubMed ID: 15195142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [When p19ARF finds a partner or new "dangerous liaisons"].
    Larsen CJ
    Bull Cancer; 1998 Jun; 85(6):523-6. PubMed ID: 9752279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic ras and p53 cooperate to induce cellular senescence.
    Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
    Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.